We estimated the relationship between the abundance of six types of tumor-infiltrating immune cells (B cells, CD4+ T cells, CD8+ T cells, dendritic cells, macrophages, and neutrophils) and the signature risk score in MIBC. The gene discussed is CD4; the disease is neoplasm.